Lucas Anderson, MD
Orthopaedic Surgery · Coeur D Alene, IDNPI 1073603692
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.0%), other and travel and lodging — rather than concentrated in one kind of arrangement. Medacta USA, Inc. accounts for 69.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $122,245 and has fallen 79.9% since, to $24,536 in 2025. Among orthopaedic surgery clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $1162.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$168K
- Zimmer Biomet$67K
- Ethicon Endo-surgery Inc.$7K
- Stryker$895
- Smith+Nephew$136
- Innovation Technologies Inc$112
- plus $143 from 2 others
Across 52 payments — averaging $4851.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$178K
- Medacta USA, Inc.$75K
What the payments were for
- Royalty or licence$19,9078%
- Consulting fees$138,56557%
- Travel & lodging$31,91413%
- Food & beverage$6,6623%
- Other$45,93719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 166 | $167,851 |
| Zimmer Biomet | 4 | $66,709 |
| Ethicon Endo-surgery Inc. | 1 | $7,140 |
| Stryker | 28 | $895 |
| Smith+Nephew | 4 | $136 |
| Innovation Technologies Inc | 1 | $112 |
| Johnson & Johnson(2 entities) | 4 | $87 |
| Convatec Inc. | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPACT$30,383
- AMISTEM$23,962
- Mpact Acetabular System$23,939
- GMK Sphere Revision System$19,616
- GMK SPHERE$18,847
- AMIStem H Femoral Stems$10,040
- QUADRA$8,690
- STRATAFIX$7,140
- DERMABOND PRINEO$7,140
- MONOCRYL$7,140
- M-VIZION$4,444
- Quadra C Femoral Stems$1,042
- MAKO$289
- MOTO UNI$135
- Versafitcup CC Trio Acetabular System$122
- Irrisept$112
- MYKNEE$105
How this compares
$242,986 in reported general payments places this provider in the 95th percentile of 139 orthopaedic surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 28 | $580 |
| Sodium Chloride0.9 % Sodium Chloride | 17 | $105 |
| Meloxicam | 23 | $104 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Coeur D Alene
- Richard StowellCoeur D Alene$22K
- Jeffrey LymanCoeur D Alene$17K
- Stefan YakelCoeur D Alene$15K
- Darren PlummerCoeur D Alene$15K
- David ParkerCoeur D Alene$12K
- Robert BleaseCoeur D Alene$6K
- Carl HumphreyEagle$9.4M
- Richard MooreBoise$7.4M
- Roman SchwartsmanBoise$358K
- Jeffry MenznerBoise$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.